The Critical Issue of Restaging Patients With Hepatocellular Carcinoma

Hepatology - United States
doi 10.1002/hep.30322
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Restaging Patients With Hepatocellular Carcinoma Before Additional Treatment Decisions: A Multicenter Cohort Study

Hepatology
MedicineHepatology
2018English

Staging and Restaging for Hepatocellular Carcinoma: Solution of Confusion?

Hepatology
MedicineHepatology
2019English

The Impact of Thyroid Hormones on Patients With Hepatocellular Carcinoma

PLoS ONE
Multidisciplinary
2017English

Effectiveness of Hepatocellular Carcinoma Surveillance in Patients With Cirrhosis

Cancer Epidemiology Biomarkers and Prevention
MedicineEpidemiologyOncology
2012English

Sorafenib vs Nivolumab in Patients With Hepatocellular Carcinoma

Journal of Liver Research, Disorders & Therapy
2017English

The Role of Novel Prognostic Scores for Patients With Hepatocellular Carcinoma

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2017English

Role of F18-FDG-Pet/Ct in Restaging Patients Affected by Renal Carcinoma

Nuclear Medicine Review
MedicineNuclear MedicineRadiologyImaging
2013English

Serum Golgi Protein 73 in Patients With Hepatocellular Carcinoma.

International Journal of Advanced Research
2017English

Clinical Manifestations and Outcomes of Patients With Sarcomatoid Hepatocellular Carcinoma

Hepatology
MedicineHepatology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy